Cargando…
Efficacy of trabectedin in metastatic solitary fibrous tumor
Solitary fibrous tumor is a rare tumor type and has an unpredictable course. Local recurrence rate varies between 9 and 19%, and rate of metastatic involvement between 0 and 36 %. It is characterized by a typical architecture and immuno-histochemistry tests. The most important prognostic factor is t...
Autores principales: | Chaigneau, Loïc, Kalbacher, Elsa, Thiery-Vuillemin, Antoine, Fagnoni-Legat, Christine, Isambert, Nicolas, Aherfi, Lionel, Pauchot, Julien, Delroeux, Delphine, Servagi-Vernat, Stephanie, Mansi, Laura, Pivot, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208416/ https://www.ncbi.nlm.nih.gov/pubmed/22066036 http://dx.doi.org/10.4081/rt.2011.e29 |
Ejemplares similares
Ejemplares similares
-
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
por: Khalifa, J., et al.
Publicado: (2015) -
Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib
por: Ghanim, Bahil, et al.
Publicado: (2022) -
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study
por: Royer, B, et al.
Publicado: (2012) -
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
por: Blay, Jean-Yves, et al.
Publicado: (2013) -
Solitary fibrous tumor
por: Bruzzone, Andrea, et al.
Publicado: (2010)